| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4006261 | American Journal of Ophthalmology | 2006 | 9 Pages |
Abstract
Microdissection genotyping holds promise as a clinical tool in integrating molecular analysis into standard histopathology to advance the understanding of lacrimal gland ACC tumorigenesis. A unique time course for temporal mutation acquisition in ACC is proposed, consisting of 1p36 loss first. Allelic loss for microsatellite markers at 1p36 may be a common as well as an early event in ACC formation and progression.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
David T. MD, Sydney D. MD, Pasquale MD, Sander MD, Joyce MS, William J. MS,